IMPORTANCE OF PEER-BASED SERVICES & NEEDLE & SYRINGE PROGRAMS (NSP)

Size: px
Start display at page:

Download "IMPORTANCE OF PEER-BASED SERVICES & NEEDLE & SYRINGE PROGRAMS (NSP)"

Transcription

1 IMPORTANCE OF PEER-BASED SERVICES & NEEDLE & SYRINGE PROGRAMS (NSP) Annie Madden Executive Officer Australian Injecting & Illicit Drug Users League (AIVL)

2 SUMMARY Who is AIVL? 2 Harm Reduction Approaches: Peer-based services Needle & Syringe Programs (NSPs) Useful resources & contacts

3 WHO IS AIVL? National peak organization for the state and territory peer-based drug user organizations and Represents people who use/have used illicit drugs at national level. Work on all issues affecting people who use/have used illicit drugs including HIV, hepatitis C, harm reduction, drug treatment, overdose, welfare reform, housing, police, courts, prisons, parenting issues, etc.

4 TUF WASUA AIVL works through member organisations & networks QUIHN & QuIVAA NUAA SAVIVE CAHMA VIVAIDS TASCAHRD AIVL

5 WHO IS AIVL? AIVL operates on a peer-based philosophy, which means the organisation is run by and for drug users and ex-drug users. AIVL promotes the health and human rights of people who use/have used illicit drugs. AIVL believes drug users have the right to be treated with dignity and respect. And to live their lives free from discrimination, stigma and human rights violations.

6 PEER-BASED SERVICES What are peer-based services? Why are peer-based services important? Some examples of peer-based services.

7 WHAT ARE PEER-BASED SERVICES? Illicit drug users (and particularly injecting drug users) are one of the most marginalized groups in the community. Illegality, shame and stigma force illicit drug users away from information, support and services. Long term effects of being locked outside of mainstream society are: Serious health problems; Unemployment; Family and community breakdown; and In many cases, premature death.

8 WHAT ARE PEER-BASED SERVICES? Peer-based services play a crucial role in linking people back into society and to support and services. How? Peer-based services are run by and for drug users and ex-drug users. Peers understand and can empathize with the issues drug users experience and this creates credibility and trust. Have unique ability to reach highly marginalized people and groups that other services cannot reach.

9 WHAT ARE PEER-BASED SERVICES? Peer-based services are based on the concept that: drug users can and do educate and learn from each other; these interactions are part of the everyday lives of drug users and can be utilized as an education, advocacy and support tool; drug users/ex-users can manage their own programs and speak on their own behalf; and drug users have first hand knowledge of the issues that affect them vital in the targeting, planning & delivery of services and in policy development.

10 WHY ARE PEER-BASED SERVICES SO IMPORTANT? Peer-based services are important because: they are based on the philosophy of empowerment; they encourage drug users and ex-users to take an active role in their health & wellbeing; they are cost-effective - capacity to reduce long term health & social costs through effective prevention; they WORK! How do we know? Australia has maintained one of the lowest rates of HIV among IDU in the world for over 20 years; and has a declining hepatitis C rate among IDU; The difference? Australia is world leader in peerbased services and organisations.

11 SOME EXAMPLES OF PEER- BASED SERVICES Many different forms of peer-based services/programs: Peer education formal and informal Peer support groups and individually based Peer advocacy - advocating on behalf of individuals Peer representation advocating & representing on behalf of drug users & ex-users as a group Peer-based needle & syringe programs Peer-based primary health clinics Peer training formal skills & capacity building courses Peer resources and materials incl. magazines

12 NEEDLE & SYRINGE PROGRAMS (NSPs) How & when did NSPs start? What range of services do NSPs offer? What s the picture in Australia? Are NSPs effective? Frequently Asked Questions

13 HOW & WHEN DID NSPs START? First NSP in Sydney in 1986 NSP has been in operation for 22 years Australia now has NSPs in all states and territories Primary outlets, secondary services, pharmacy, vending machines Over 900 NSP outlets in Australia (does not include pharmacies)

14 RANGE OF SERVICES NSW NSPs OFFER? Access to new injecting equipment Needles & syringes Other equipment (spoons, swabs, water) Disposal containers Specialised equipment (large barrels, butterflies, pill/bacterial filters, etc) Education & harm reduction information Ancillary services BBV & sexual health screening, Hep B vaccination, vein care, etc. Referrals to drug treatment and other health, social and legal services

15 WHAT S THE PICTURE? Primary outlets NSP specialist services Secondary outlets community health, youth & AOD services, A&E Depts. Mobile Outreach & Pedestrian Outreach Pharmacy outlets majority under Pharmacy NSP Scheme, small number (2-5% of total distribution) independent. Over 35 million N&S distributed nationally each year. Almost 95% of respondents in National NSP Survey reported using new N&S for all (72%) or most injections (22%)

16 ARE NSPs EFFECTIVE? Nationally Return on Investment Study 2002 between 1991 and 2000 Australian NSPs are estimated to have: Prevented approximately 25,000 HIV transmissions among people who inject drugs; Saved over $7 million in HIV/AIDS lifetime treatment costs; Prevented approx 21,000 cases of hepatitis C transmissions among people who inject drugs between 1988 and 2000; and Saved an estimated $783 million in HCV lifetime treatment costs.

17 ARE NSPs EFFECTIVE? Nationally Return on Investment Study 2002 between 1991 and 2000 Australian NSPs are estimated to have: Provide a return on investment of $7.7 billion for Provide a return on investment of $7.7 billion for an investment of $150 million over 10 years. Major cities that implemented NSP prior to 1997 have seen an 8% decline in the rate of HIV & HCV infections. Major cities without NSP have seen an 18% increase in HIV & HCV infections in the same time period.

18 ARE NSPs EFFECTIVE? NSW Return on Investment in HIV/AIDS Programs 2007 found that: Return on investment in HIV prevention programs direct cost to direct benefit ratio of 1:13 (every $1 invested/$13 saved); Compared to 1:2 (Tobacco) and 1:0.70 (Heart Disease) Prevented 44,500 cases of HIV with 75% of these among IDU; Representing a 99% reduction in HIV cases that would otherwise have occurred among IDU; Saved an estimated $18 million in HIV lifetime treatment costs through prevention programs.

19 FREQUENTLY ASKED? Does NSP increase/encourage injecting drug use? Answer: No. International research (WHO) has shown NSP does not increase rates of or recruitment to injecting drug use. Indeed research has found NSP attendees are more likely to cease injecting due to access to drug treatment referrals. Does NSP send a message that society has given up on preventing drug use? Answer: No. NSP is only one strategy among many and can work along-side law enforcement, drug treatment, etc.

20 FREQUENTLY ASKED? Does NSP increase needles & syringes discarded on the streets? Answer: No. Most Australian NSPs have regular return rates of over 90% Levels of discarded used injecting equipment has decreased since introduction of NSP. NSP can run programs to collect and clean-up local hot-spots Never been a recorded case of HIV, hepatitis C or hepatitis B by a member of the Australian public following a needle-stick from a publicly discarded syringe.

21 FREQUENTLY ASKED? Do NSP save lives? Answer: ABSOLUTELY!!! NSP is about keeping people alive and as healthy as possible while they are using. You cannot refer a person who has died from a drug-related overdose or HIV/AIDS to drug treatment. NSP = a humane, compassionate and pragmatic response to a global public health issue.

22 FURTHER RESOURCES IHRA Global State of Harm Reduction Report May NSP - Questions Answered & NSP - Review of the Evidence National NSP Survey Returns on Investment in NSP Study NSW Return on HIV/AIDS Investment AIVL Disposal Report & NEP in Prisons

23 CONTACT DETAILS My Details: Annie Madden Executive Officer Australian Injecting & Illicit Drug Users League (AIVL) Ph: (02) Website:

Needle and Syringe Programs - 17 October 2013

Needle and Syringe Programs - 17 October 2013 Needle and Syringe Programs - 17 October 2013 ANCD Position Paper: Needle and Syringe Programs MEDIA RELEASE 17 October 2013 The Australian National Council on Drugs (ANCD) has today released a position

More information

Dr Angella Duvnjak. CEO, Australian Injecting and Illicit Drug Users League. Dr Angella Duvnjak Viral Hepatitis Conference

Dr Angella Duvnjak. CEO, Australian Injecting and Illicit Drug Users League. Dr Angella Duvnjak Viral Hepatitis Conference Dr Angella Duvnjak CEO, Australian Injecting and Illicit Drug Users League Conference 2016 1 Traditional owners of the land Collaborative effort of the AIVL staff team on the projects presented today The

More information

Australian Injecting and Illicit Drug Users League. Policy Position Paper 8 Retractable Syringes

Australian Injecting and Illicit Drug Users League. Policy Position Paper 8 Retractable Syringes Australian Injecting and Illicit Drug Users League Policy Position Paper 8 Retractable Syringes June 2003 Discussion A retractable device is a combination needle and syringe where the needle goes back

More information

DRUG DIVERSION STUDY TOUR ANNIE MADDEN EXECUTIVE OFFICER AUSTRALIAN INJECTING AND ILLICIT DRUG USERS LEAGUE (AIVL)

DRUG DIVERSION STUDY TOUR ANNIE MADDEN EXECUTIVE OFFICER AUSTRALIAN INJECTING AND ILLICIT DRUG USERS LEAGUE (AIVL) DRUG DIVERSION STUDY TOUR ANNIE MADDEN EXECUTIVE OFFICER AUSTRALIAN INJECTING AND ILLICIT DRUG USERS LEAGUE (AIVL) Overview Who is AIVL? Drug User Networks globally Nothing about us without us why is MIPUD

More information

What is harm reduction?

What is harm reduction? What is harm reduction? The International Harm Reduction Association (IHRA) defines harm reduction as the policies, programmes and practices that aim to reduce the harms associated with the use of psychoactive

More information

Drug Use, Harm Reduction, and HIP

Drug Use, Harm Reduction, and HIP Drug Use, Harm Reduction, and HIP Strategies for Engaging PWIDs in HIV Prevention Services Presented by: Katie Burk, MPH Narelle Ellendon, RN Harm Reduction Coalition Founded in 1993 by needle exchange

More information

Legislative and Policy Barriers to Needle & Syringe Programs and Injecting Equipment Access for People Who Inject Drugs

Legislative and Policy Barriers to Needle & Syringe Programs and Injecting Equipment Access for People Who Inject Drugs Legislative and Policy Barriers to Needle & Syringe Programs and Injecting Equipment Access for People Who Inject Drugs Australian Injecting and Illicit Drug Users League (AIVL) 2010 Contents About AIVL

More information

The information provided should be used as a guide only and is not a substitute for medical advice.

The information provided should be used as a guide only and is not a substitute for medical advice. Liver first Welcome to the revised version of Liver First which has been produced by the Australian Injecting & Illicit Drug Users League (AIVL). AIVL aims to provide accurate information to help people

More information

Re Joint Committee on Law Enforcement Inquiry into crystal methamphetamine (ice)

Re Joint Committee on Law Enforcement Inquiry into crystal methamphetamine (ice) AUSTRALIAN FEDERATION OF AIDS ORGANISATIONS INC. ABN 91 708 310 631 Committee Secretary Parliamentary Joint Committee on Law Enforcement PO Box 6100 Parliament House Canberra ACT 2600 PO Box 51 Newtown

More information

Needle Exchange Programs

Needle Exchange Programs Needle Exchange Programs Are they right for your community? Deena Dodd Indiana Rural Health Association 2017 Indiana General Assembly House Bill #1438 Syringe exchange programs: Allows a county or municipality

More information

ESTABLISHMENT OF SUPERVISED INJECTING FACILITY IN VICTORIA SUBMITTED BY THE SALVATION ARMY

ESTABLISHMENT OF SUPERVISED INJECTING FACILITY IN VICTORIA SUBMITTED BY THE SALVATION ARMY ESTABLISHMENT OF SUPERVISED INJECTING FACILITY IN VICTORIA SUBMITTED BY THE SALVATION ARMY 06 APRIL 2017 The Salvation Army, State Social Command (Victoria) Establishment of Supervised Injecting Facility

More information

Part of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia

Part of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia Part of the Continuum of Care Harm Reduction Gino Vumbaca President Harm Reduction Australia What is Harm Reduction The defining features are the focus on the reduction of harm, rather than on the prevention

More information

Injecting Equipment Provision in Scotland Survey 2011/12

Injecting Equipment Provision in Scotland Survey 2011/12 Publication Report Injecting Equipment Provision in Scotland Survey 25 June 2013 An Official Statistics Publication for Scotland Contents Introduction... 2 Key points... 3 Results and Commentary... 4 1.

More information

PH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes

PH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes PH52 Audit tool for the implementation of NICE public health guidance 52 Needle and syringe programmes Introduction This audit tool has been developed to help you audit implementation of, and compliance

More information

who use drugs in order to assist them in reducing harm while in the cycle of addiction

who use drugs in order to assist them in reducing harm while in the cycle of addiction August 16, 2016 } Accepts that illicit drug use is part of our world, and chooses to minimize its harmful effects rather than ignore or condemn them } Calls for the provision of services to people who

More information

POLICY POSITION. Access to Hepatitis C Treatments

POLICY POSITION. Access to Hepatitis C Treatments POLICY POSITION Access to Hepatitis C Treatments Discussion Hepatitis C is the most common notifiable communicable disease in Australia, with an estimation of as many as 1.1% of all Australians infected

More information

Hepatitis C Strategy. About us. What is hepatitis C?

Hepatitis C Strategy. About us. What is hepatitis C? Hepatitis C Strategy About us We support people to take control of their lives and make positive changes. For fifty years we have made a difference to people who want to change their relationship with

More information

Submission to the Tasmanian Government. A Healthy Tasmania Five Year Strategic Plan Community Consultation Draft

Submission to the Tasmanian Government. A Healthy Tasmania Five Year Strategic Plan Community Consultation Draft Submission to the Tasmanian Government A Healthy Tasmania Five Year Strategic Plan Community Consultation Draft February 2016 Alcohol, Tobacco and other Drugs Council of Tas Inc. (ATDC) www.atdc.org.au

More information

Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018

Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018 Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018 Overview Background to injecting drug use Overview of harm reduction Data on Hepatitis Summary of services provided by

More information

January Treatment Centre. December Drop-In Centre. November Regional Office

January Treatment Centre. December Drop-In Centre. November Regional Office Dristi Nepal (By and for female drug users organization in Nepal) Di Dristi inepal was the first organization i to be established by and for female drug user s to deliver services in Nepal. We are based

More information

Guidelines For Services Providing Injecting Equipment

Guidelines For Services Providing Injecting Equipment Guidelines For Services Providing Injecting Equipment Best Practice Recommendations For Commissioners and Injecting Equipment Provision (IEP) Services in Scotland (Scottish Government 2010) January 2014

More information

New South Wales Needle and Syringe Program Enhanced Data Collection

New South Wales Needle and Syringe Program Enhanced Data Collection New South Wales Needle and Syringe Program Enhanced Data Collection 2017 A report for the NSW Ministry of Health by the Kirby Institute, UNSW Australia August 2017 Prepared by Ms Louise Geddes, Dr Jenny

More information

Preventing Harm from Substance Use: Harm Reduction. July 6, Dr. Murray Fyfe Medical Health Officer Vancouver Island Health Authority

Preventing Harm from Substance Use: Harm Reduction. July 6, Dr. Murray Fyfe Medical Health Officer Vancouver Island Health Authority Preventing Harm from Substance Use: Harm Reduction July 6, 2009 Dr. Murray Fyfe Medical Health Officer Vancouver Island Health Authority Substance Dependence Substance use spans from abstinence, to beneficial

More information

Blood-borne viruses in marginalised populations

Blood-borne viruses in marginalised populations Blood-borne viruses in marginalised populations 2 May 2014 SYDNEY MEDICAL SCHOOL Bethany White, PhD Discipline of Addiction Medicine Overview Blood-borne viruses: HIV Hepatitis B virus (HBV) Hepatitis

More information

Needle Syringe Program National Minimum Data Collection. Data Dictionary

Needle Syringe Program National Minimum Data Collection. Data Dictionary Needle Syringe Program National Minimum Data Collection Data Dictionary 2017 Needle Syringe Program National Minimum Data Collection Data Dictionary 2017.v3 Prepared by Ms Sue Linsen, Dr Jenny Iversen,

More information

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs, U N A I D S B E S T P R A C T I C E C O L L E C T I O N Drug use and HIV/AIDS UNAIDS statement presented at the United Nations General Assembly Special Session on Drugs Joint United Nations Programme on

More information

Part 1: Introduction & Overview

Part 1: Introduction & Overview Part 1: Introduction & Overview We envision a collaborative, participative partnership around IDU that: Provides all relevant and interested stakeholders with a voice and role. Promotes awareness of the

More information

Integrated harm reduction services for drug users and homeless people. Katrin Schiffer

Integrated harm reduction services for drug users and homeless people. Katrin Schiffer Integrated harm reduction services for drug users and homeless people Katrin Schiffer Content Introduction Presentation of Correlation Network Harm Reduction in a nutshell basic principles and critical

More information

Technical Guidance Note for Global Fund HIV Proposals

Technical Guidance Note for Global Fund HIV Proposals Technical Guidance Note for Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including this activity in the proposal The World Health Organization (WHO), the Joint United

More information

Victorian AIDS Council Gay Men s Health Centre

Victorian AIDS Council Gay Men s Health Centre Victorian AIDS Council Gay Men s Health Centre including the Positive Living Centre VAC Reg. No. A 3609 GMHC Reg No. A0010550F VAC ABN 52 907 644 835 GMHC ABN 87 652 472 253 AUSTRALIAN GOVERNMENT DEPARTMENT

More information

Leading Australia towards the elimination of viral hepatitis

Leading Australia towards the elimination of viral hepatitis Leading Australia towards the elimination of viral hepatitis Australian Federal Election 2016 About Hepatitis Australia Our vision is an end to hepatitis B and hepatitis C in Australia. Our mission is

More information

September Contact John Rogerson Chief Executive Officer Alcohol and Drug Foundation Executive Summary adf.org.

September Contact John Rogerson Chief Executive Officer Alcohol and Drug Foundation Executive Summary adf.org. AN EXECUTIVE SUMMARY OF EVIDENCE PUT TO THE INQUIRY INTO THE DRUGS, POISONS AND CONTROLLED SUBSTANCES AMENDMENT (PILOT MEDICALLY SUPERVISED INJECTING CENTRE BILL) 2017 September 2017 Contact John Rogerson

More information

Background. Population/Intervention(s)/ Comparison/Outcome(s) (PICO)

Background. Population/Intervention(s)/ Comparison/Outcome(s) (PICO) updated 2012 Role of sterile injection equipment and outreach programmes for injecting drug users Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related

More information

WA DRUG ABUSE STRATEGY OFFICE

WA DRUG ABUSE STRATEGY OFFICE WA DRUG ABUSE STRATEGY OFFICE WA Drug Abuse Strategy Office Statistical Bulletin Number 6, February 2 Statistical Bulletin Number 6, February 2 DISTRIBUTION OF NEEDLES & SYRINGES IN WA, 1987-19 Introduction

More information

Overview of Evidence for Sterile Syringe Access. Hilary McQuie Western Director Harm Reduction Coalition

Overview of Evidence for Sterile Syringe Access. Hilary McQuie Western Director Harm Reduction Coalition Overview of Evidence for Sterile Syringe Access Hilary McQuie Western Director Harm Reduction Coalition Working Definition of Harm Reduction Harm Reduction: A set of practical, public health strategies

More information

Addiction and Substance misuse pathways

Addiction and Substance misuse pathways Addiction and Substance misuse pathways Gordon Morse Chief Medical Officer Turning Point UK Gordon Morse statement of interests Sole employer Turning Point Some unpaid advisory work to the Hepatitis C

More information

>Hepatitis NSW will continue to

>Hepatitis NSW will continue to Continued Equal Treatment Access to hepatitis C medicines KURT SAYS Everyone with viral hepatitis deserves equal access to treatment. Thankfully Australians can access hepatitis C treatment before they

More information

Overview of Syringe Exchange Programs. New York City Police Academy November 24, 2004

Overview of Syringe Exchange Programs. New York City Police Academy November 24, 2004 Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004 History of Syringe Exchange n Title 10 N.Y.C.R.R. 80.131 (a) (2), 80.135. n Enacted in 1992 in response to the HIV/AIDS

More information

Continued in Part II (additional reading list at end of Part II)

Continued in Part II (additional reading list at end of Part II) Stigma, HIV, and IDU in Thailand - Part I Karyn Kaplan, Paisan Suwannawong, Key Resource People, Thailand ******************************************************** "THAILAND IS RENOWNED FOR ITS SUCCESSFUL

More information

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings Facilitator: Liz Hall, CDPH Office of AIDS Matt Curtis,

More information

Local Legislative Approval and Program Certification

Local Legislative Approval and Program Certification Syringe Services Programs: Implementation Brief St. Louis County, Missouri Introduction Syringe services programs (SSPs), also known as needle exchange or syringe access programs, are an integral component

More information

Addiction Therapy-2014

Addiction Therapy-2014 Addiction Therapy-2014 Chicago, USA August 4-6, 2014 Cynthia Stuhlmiller Harm Reduction, New Recovery and Addiction Therapy Cynthia Stuhlmiller, Professor of Rural Nursing University of New England, Armidale,

More information

EMBARGOED NOT FOR RELEASE PRIOR TO AM WEDNESDAY OCTOBER

EMBARGOED NOT FOR RELEASE PRIOR TO AM WEDNESDAY OCTOBER Media Release National Drug and Alcohol Research Centre EMBARGOED NOT FOR RELEASE PRIOR TO 12.05 AM WEDNESDAY OCTOBER 14 2015 Crystal methamphetamine use increases by six per cent among people who inject

More information

UNAIDS 2016 THE AIDS EPIDEMIC CAN BE ENDED BY 2030 WITH YOUR HELP

UNAIDS 2016 THE AIDS EPIDEMIC CAN BE ENDED BY 2030 WITH YOUR HELP UNAIDS 2016 THE AIDS EPIDEMIC CAN BE ENDED BY 2030 WITH YOUR HELP WHY UNAIDS NEEDS YOUR SUPPORT Over the past 35 years, HIV has changed the course of history. The massive global impact of AIDS in terms

More information

Integrating hepatitis C treatment in a regional setting The Cairns Experience. DANA 2018 Morag Goodinson

Integrating hepatitis C treatment in a regional setting The Cairns Experience. DANA 2018 Morag Goodinson Integrating hepatitis C treatment in a regional setting The Cairns Experience DANA 2018 Morag Goodinson I would like to acknowledge the Traditional Owners of the land, and pay respect to Elders past, present

More information

Pharmacy Needle and Syringe Survey, New South Wales

Pharmacy Needle and Syringe Survey, New South Wales MONOGRAPH 2/2010 Pharmacy Needle and Syringe Survey, New South Wales 2006 2008 Joanne Bryant Hannah Wilson Peter Hull Carla Treloar MONOGRAPH 2/2010 Pharmacy Needle and Syringe Survey, New South Wales

More information

Becoming a harm reduction distribution agency in Toronto - information session

Becoming a harm reduction distribution agency in Toronto - information session Becoming a harm reduction distribution agency in Toronto - information session Kris Guthrie, RN BScN Health Promotion Specialist, The Works Toronto Public Health May 2016 Overview Brief backgrounder Harm

More information

HIV AND PEOPLE WHO INJECT DRUGS

HIV AND PEOPLE WHO INJECT DRUGS UNAIDS 2017 HIV AND PEOPLE WHO INJECT DRUGS People who use and inject drugs are among the groups at highest risk of exposure to HIV, but remain marginalized and out of reach of health and social services.

More information

COMMUNITY CONSULTATION SERIES Women Who Have Sex With Women (WSW) and HIV Prevention

COMMUNITY CONSULTATION SERIES Women Who Have Sex With Women (WSW) and HIV Prevention COMMUNITY CONSULTATION SERIES Women Who Have Sex With Women (WSW) and HIV Prevention Presented by: The Institute @ Harm Reduction Coalition May 14, 2010 Harm Reduction Coalition Founded in 1994 to work

More information

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations cessation of use may be the most effective form of harm reduction but, in reality, many clients do not wish to cease using, or find it too difficult. (Addy & Ritter, 2000, p.1) Introduction Historically,

More information

Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario

Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Views expressed in the attached document do not necessarily represent those of the Ministry of Health and Long Term Care or those

More information

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009 The role of UNODC in working law enforcement agencies to promote harm reduction IHRC, Bangkok, 23 April 2009 Drug control has focused mostly on law enforcement Public health which is the first principle

More information

Victorian Parliamentary Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017

Victorian Parliamentary Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017 Victorian Parliamentary Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017 19 April 2017 That the Government: VHA Recommendations

More information

Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014

Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014 Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014 1 Q: What are Supervised Injecting Facilities? A: These are places where people who inject drugs can go to inject in relative

More information

TREATMENT OF RECENTLY ACQUIRED HEPATITIS C VIRUS INFECTION (ATAHC II)

TREATMENT OF RECENTLY ACQUIRED HEPATITIS C VIRUS INFECTION (ATAHC II) TREATMENT OF RECENTLY ACQUIRED HEPATITIS C VIRUS INFECTION (ATAHC II) A national study to find the best treatment strategy for people with recently acquired hepatitis C infection. introduction This information

More information

Hepatitis C The facts

Hepatitis C The facts Hepatitis C The facts 2 Hepatitis C The facts What is hepatitis? Hepatitis means inflammation of the liver. The liver is a vital part of the body. If it does not work properly, it can cause serious illness.

More information

Substance use and misuse

Substance use and misuse CENTRE FOR PHARMACY POSTGRADUATE EDUCATION Substance use and misuse A CPPE workshop to support local public health services Pre-workshop book PH/SUBSUSE14/PW August 2014 Substance use and misuse - Pre-workshop

More information

Drug Consumption Rooms: Legal barriers or just an excuse? Kirstie Douse Head of Legal Services Solicitor Advocate

Drug Consumption Rooms: Legal barriers or just an excuse? Kirstie Douse Head of Legal Services Solicitor Advocate Drug Consumption Rooms: Legal barriers or just an excuse? Kirstie Douse Head of Legal Services Solicitor Advocate What is a DCR? A facility that allows people to inject/smoke illicitly purchased drugs,

More information

PART 2: BEST PRACTICE RECOMMENDATIONS

PART 2: BEST PRACTICE RECOMMENDATIONS PART 2: BEST PRACTICE RECOMMENDATIONS FOR CANADIAN HARM REDUCTION PROGRAMS THAT PROVIDE SERVICE TO PEOPLE WHO USE DRUGS AND ARE AT RISK FOR HIV, HCV, AND OTHER HARMS Carol Strike and the Working Group

More information

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.

More information

Eliminating Viral Hepatitis in Australia: Where are we in 2017?

Eliminating Viral Hepatitis in Australia: Where are we in 2017? This document was prepared by Hepatitis Australia in consultation with a variety of stakeholders working in the areas of hepatitis B and hepatitis C in Australia. This included people involved in primary

More information

AUSTRALIAN NSP SURVEY NATIONAL DATA REPORT

AUSTRALIAN NSP SURVEY NATIONAL DATA REPORT Needle Syringe Programs and Harm Reduction Services in Australia AUSTRALIAN NSP SURVEY NATIONAL DATA REPORT - Prevalence of HIV, HCV and injecting and sexual behaviour among NSP attendees The Australian

More information

PERFORMANCE AND IMAGE ENHANCING DRUGS

PERFORMANCE AND IMAGE ENHANCING DRUGS PERFORMANCE AND IMAGE ENHANCING DRUGS Injectors access to needle syringe programs Presented at the 2014 National Drug Trends Conference Sydney 20 October 2014 Dr Karen J Chronister Overview Background

More information

What is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund

What is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund What is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund Outline How do we monitor drug trends in Australia Aims Methodology Drug

More information

Building a New Approach to Health Care Services for Hard to Reach Clients

Building a New Approach to Health Care Services for Hard to Reach Clients Building a New Approach to Health Care Services for Hard to Reach Clients Community Discussion and Open House January 30, 2013 Fernwood Community Association 1923 Fernwood Street February 6, 2013 North

More information

NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA

NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA Dr. Audronė Astrauskienė Drug control department under the Government of the Republic of Lithuania 2010 10 25 Harm reduction services development in

More information

Addressing Drug Addiction in Australia

Addressing Drug Addiction in Australia The ICE Epidemic: Addressing Drug Addiction in Australia A White Paper 24 August 2015 Rev. Angel Roldán Life-Gate Inc. PO Box 11097 Frankston VIC 3199 Australia www.life-gate.org Contents 1. Introduction

More information

MOBILE OUTREACH. A guide to help plan and implement a Mobile Outreach Vehicle (MOV)-based risk reduction intervention program.

MOBILE OUTREACH. A guide to help plan and implement a Mobile Outreach Vehicle (MOV)-based risk reduction intervention program. This guide is designed to help Community-Based Organizations (CBOs) and other individuals or groups in the planning and implementation of a Mobile Outreach Vehicle (MOV)-based risk-reduction intervention

More information

Syringe Exchange Programs December 2005

Syringe Exchange Programs December 2005 Syringe Exchange Programs December 2005 In 1997, a Report to Congress concluded that needle exchange programs can be an effective component of a comprehensive strategy to prevent HIV and other blood-borne

More information

Harm Reduction in Nigeria

Harm Reduction in Nigeria Harm Reduction in Nigeria Needs, gaps, and responses to ensure access to effective HIV prevention, treatment and care for people who inject drugs February 2018 This document is made possible by the generous

More information

QuADS Organisational Standards and Professional Competencies in needle exchange

QuADS Organisational Standards and Professional Competencies in needle exchange QuADS Organisational Standards and Professional Competencies in needle exchange N This briefing paper was funded by the Department of Health as part of their 'Making Harm Reduction Work' initiative. DrugScope/Department

More information

Country progress report - Bangladesh. Global AIDS Monitoring 2017

Country progress report - Bangladesh. Global AIDS Monitoring 2017 Country progress report - Bangladesh Global AIDS Monitoring 2017 2 Contents Overall - Fast-track targets Commitment 1 - Ensure that 30 million people living with HIV have access to treatment through meeting

More information

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Aljona Kurbatova National Institute for Health Development Estonia Estimated number of people who inject

More information

AUSTRALIAN NSP SURVEY

AUSTRALIAN NSP SURVEY AUSTRALIAN NSP SURVEY Prevalence of HIV, HCV and injecting and sexual behaviour among Needle and Syringe Program attendees 20 YEAR NATIONAL DATA REPORT 1995-2014 Report prepared by Jenny Iversen and Lisa

More information

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery Drug Policy, Harm Reduction, and What s Next The start or lack thereof of Drug Policy in the United States The Harrison Narcotics

More information

Prevention Point Philadelphia

Prevention Point Philadelphia Integrating Hepatitis C Prevention, Care, Education, and Referrals in a Clinical & Social Service Setting By Iredia Olaye Primary Care & HCV Outreach, Linkage & Referral Specialist Prevention Point Philadelphia

More information

End AIDS: The HIV Prevention & Outreach Summit Call for Workshop Submissions

End AIDS: The HIV Prevention & Outreach Summit Call for Workshop Submissions End AIDS: The HIV Prevention & Outreach Summit Call for Workshop Submissions What is End AIDS: The HIV Prevention & Outreach Summit? End AIDS: The HIV Prevention and Outreach Summit is a conference that

More information

Services and Support Information Leaflet

Services and Support Information Leaflet Services and Support Information Leaflet Services Free HIV and STI Testing Free HIV and STI testing takes place in HIV Ireland on the second and fourth Wednesdays of every month ( exclusive of holidays

More information

Pharmacy Needle and Syringe Programme. Enhanced Contract

Pharmacy Needle and Syringe Programme. Enhanced Contract Pharmacy Needle and Syringe Programme Enhanced Contract 1 st April 2012 31 st March 2013 Signed on behalf of LPC Signed on behalf of CRI Signed on behalf of Turning Point Signed on behalf of KCA Signed

More information

Rural Prevention and Treatment of Substance Abuse Toolkit

Rural Prevention and Treatment of Substance Abuse Toolkit Rural Prevention and Treatment of Substance Abuse Toolkit September 18, 2017 Tricia Stauffer, MPH NORC Walsh Center for Rural Health Analysis Rural Health Outreach Tracking and Evaluation Program Funded

More information

Preparedness for candidate HCV vaccine trials in people who inject. C Vaccine Initiative*

Preparedness for candidate HCV vaccine trials in people who inject. C Vaccine Initiative* Preparedness for candidate HCV vaccine trials in people who inject drugs: Challenges and opportunities Li M h b h lf f th UNSW H titi Lisa Maher, on behalf of the UNSW Hepatitis C Vaccine Initiative* Background

More information

The Silent Disease Inquiry into Hepatitis C in Australia

The Silent Disease Inquiry into Hepatitis C in Australia Australian Government response to the House of Representatives Standing Committee on Health report: The Silent Disease Inquiry into Hepatitis C in Australia November 2016 LIST OF ABBREVIATIONS AHPPC Australian

More information

Training Objectives. By the end of this session you will be able to: 2. Recognize key principles of harm reduction.

Training Objectives. By the end of this session you will be able to: 2. Recognize key principles of harm reduction. Training Objectives By the end of this session you will be able to: 1. Define harm reduction. 2. Recognize key principles of harm reduction. 3. Identify the need for harm reduction, with a PWID focus.

More information

The Pillars Approach: A Case Study

The Pillars Approach: A Case Study The Pillars Approach: A Case Study Dorothy J. Chaney, M.Ed. CADCA Trainer www.cadca.org Building Safe, Healthy, and Drug Free Communities Learning Objectives Discover how the pillars approach utilizes

More information

Questions & Answers. What are the risks associated with consumption drug use?

Questions & Answers. What are the risks associated with consumption drug use? Questions & Answers What are the risks associated with consumption drug use? Consumption drug use affects us all. Harms associated with consumption drug use are many and include the spread of infectious

More information

What is injection drug use?

What is injection drug use? What is injection drug use? Essential Standards 7.ATOD.1 Understand the health risks associated with alcohol, tobacco, and other drug use. Clarifying Objectives 7.ATOD.1.2 - Explain health risks resulting

More information

Harm Reduction in a Clinical Encounter: Collecting substance use history in a non-judgmental manner

Harm Reduction in a Clinical Encounter: Collecting substance use history in a non-judgmental manner Testing and prevention of hepatitis C for people who inject drugs Do your patients understand the importance of hepatitis C testing and prevention? Taking an accurate and non-judgmental history of substance

More information

High Impact Prevention for People Who Inject Drugs. June 30, 2015

High Impact Prevention for People Who Inject Drugs. June 30, 2015 High Impact Prevention for People Who Inject Drugs June 30, 2015 Webinar Agenda Introduction & Background o NASTAD Drug User Health: Challenges and Opportunities for Health Departments o Alessandra Ross,

More information

HEP B UNITED: YEAR-IN-REVIEW

HEP B UNITED: YEAR-IN-REVIEW HEP B UNITED: YEAR-IN-REVIEW Hep B United Summit 2018 #HepBUnite #justb OUR MISSION, GOALS, AND PRIORITIES Hep B United is a national coalition dedicated to reducing the health disparities associated with

More information

No one likes using the dirties

No one likes using the dirties No one likes using the dirties Written by Angella Duvnjak, Ele Morrison, Annie Madden and Anna Olsen PAGE 1 The Australian Injecting and illicit Drug Users League (AIVL) is the national peak organisation

More information

HIV and AIDS stigma and discrimination reduction through raising awareness in Kabul city, Afghanistan

HIV and AIDS stigma and discrimination reduction through raising awareness in Kabul city, Afghanistan HIV and AIDS stigma and discrimination reduction through raising awareness in Kabul city, Afghanistan Afghan Family Guidance Association (AFGA) Dr. Naimatullah Akbari CEO, AFGA The South Asia Regional

More information

Alcohol health promotion utilising a harm minimisation approach PREVENTIVE HEALTH MATTERS WEBINAR

Alcohol health promotion utilising a harm minimisation approach PREVENTIVE HEALTH MATTERS WEBINAR Alcohol health promotion utilising a harm minimisation approach PREVENTIVE HEALTH MATTERS WEBINAR ALCOHOL IS A DRUG Drinking alcohol is the most common type of drug use in Australia Despite, Ice epidemic,

More information

ETHNO-EPIDEMIOLOGICAL APPROACHES TO UNDERSTANDING DRUG-RELATED RELATED HARM

ETHNO-EPIDEMIOLOGICAL APPROACHES TO UNDERSTANDING DRUG-RELATED RELATED HARM ETHNO-EPIDEMIOLOGICAL APPROACHES TO UNDERSTANDING DRUG-RELATED RELATED HARM Combining Social Epidemiology and Ethnography to Study Health among Injection Drug Users in Vancouver Will Small 1,2 Evan Wood

More information

Michael Levy Australian National University

Michael Levy Australian National University Treatment is Prevention Do not under-estimate the importance of prevention as the key to treatment Michael Levy Australian National University The Burden World Health Assembly (2014) 1.4 million deaths

More information

Government of Canada Federal AIDS Initiative Milestones

Government of Canada Federal AIDS Initiative Milestones HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for

More information

Working for Health, Justice and Partnership

Working for Health, Justice and Partnership Dr Tessa Boyd-Caine plenary at National Aboriginal Community Controlled Health Organisations National Conference; 6 December 2016, Melbourne Working for Health, Justice and Partnership Thank you to Bill

More information

Positive Life NSW Business Plan: July 1, 2013

Positive Life NSW Business Plan: July 1, 2013 1 Lead the community response in HIV health policy, treatments uptake and contributions to research, to ensure that the interests of people living with and affected by HIV are central in advocacy, representation

More information

Regional Program Harm Reduction Works Fund It! Baseline assessment. Country: Georgia. Preliminary analysis. 10 October 2014

Regional Program Harm Reduction Works Fund It! Baseline assessment. Country: Georgia. Preliminary analysis. 10 October 2014 Regional Program Harm Reduction Works Fund It! Baseline assessment Country: Georgia Preliminary analysis 10 October 2014 Main constraints The formation of representative bodies, such is CCM, is not transparent.

More information

Plain language review of illicit drug use among Aboriginal and Torres Strait Islander people

Plain language review of illicit drug use among Aboriginal and Torres Strait Islander people Australian Indigenous HealthReviews From the Australian Indigenous HealthInfoNet Plain language review of illicit drug use among Aboriginal and Torres Strait Islander people Joanne Hoareau Australian Indigenous

More information

Albuquerque Health Care for the Homeless (AHCH)

Albuquerque Health Care for the Homeless (AHCH) Albuquerque Health Care for the Homeless (AHCH) Access to Harm Reduction and Syringe Exchange Services are Social Justice Issues The New Mexico Public Health Association & the New Mexico Center for the

More information